Reachable workspace in facioscapulohumeral muscular dystrophy (FSHD) by kinect-Reference-Cited by-同舟云学术

Reachable workspace in facioscapulohumeral muscular dystrophy (FSHD) by kinect

Published:2014-11-19 Issue:2 Volume:51 Page:168-175
ISSN:0148-639X
Container-title:Muscle & Nerve
language:en
Short-container-title:Muscle Nerve

Author:

Han Jay J.¹,Kurillo Gregorij¹²,Abresch Richard T.¹,de Bie Evan¹,Nicorici Alina¹,Bajcsy Ruzena²

Affiliation:

1. University of California at Davis School of Medicine; Department of Physical Medicine and Rehabilitation; 4860 Y Street, Suite 3850 Sacramento California 95817 USA

2. University of California at Berkeley College of Engineering; Department of Electrical Engineering and Computer Science; Berkeley California USA

Funder

National Science Foundation

National Institute on Disability and Rehabilitation Research

National Institute of Arthritis and Musculoskeletal and Skin Diseases

Publisher

Wiley

Subject

Physiology (medical),Cellular and Molecular Neuroscience,Neurology (clinical),Physiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/mus.24287/fullpdf

Reference28 articles.

1. Facioscapulohumeral muscular dystrophy;Tawil;Neurotherapeutics,2008

2. Genetic characterization of a large, historically significant Utah kindred with facioscapulohumeral dystrophy;Flanigan;Neuromuscul Disord,2001

3. Facioscapulohumeral muscular dystrophy: epidemiological and molecular study in a north-east Italian population sample;Mostacciuolo;Clin Genet,2009

4. FSHD associated DNA rearrangements are due to deletions of integral copies of a 3.2 kb tandemly repeated unit;Deutekom;Hum Mol Genet,1993

5. Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy;Wijmenga;Nat Genet,1992

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. French National Protocol for diagnosis and care of facioscapulohumeral muscular dystrophy (FSHD);Journal of Neurology;2024-07-02

2. An open-label pilot study of losmapimod to evaluate the safety, tolerability, and changes in biomarker and clinical outcome assessments in participants with facioscapulohumeral muscular dystrophy type 1;Journal of the Neurological Sciences;2024-07

3. Draft Guidance for Industry Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, and Related Dystrophinopathies – Developing Potential Treatments for the Entire Spectrum of Disease;Journal of Neuromuscular Diseases;2024-03-05

4. Evaluation of Upper Extremity Reachable Workspace in Children With Brachial Plexus Birth Injury;The Journal of Hand Surgery;2024-02

5. The use of digital outcome measures in clinical trials in rare neurological diseases: a systematic literature review;Orphanet Journal of Rare Diseases;2023-08-02